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Introduction
codes including AS, HF and AMI is mandatory for reimbursement in the Swedish tax-financed healthcare system. [21] [22] [23] [24] [25] [26] 
Methods

Nation-wide registers
The Swedish adult (>18 years) population between 1989 and 2009 was studied using nation-wide registers. All patients with a first hospital discharge diagnosis of AS, HF and AMI were identified from the Swedish Hospital Discharge Register (HDR) using diagnosis codes described below. 21 Patients undergoing aortic valve replacement for AS were also identified from the HDR. Reporting to the HDR is mandatory and has been nation-wide since 1987. From 2001 diagnoses from hospital outpatient visits are also registered in HDR. Reimbursement to the departments from the Swedish tax-financed healthcare system is based on such diagnosis codes.
Primary diagnoses of AS, HF and AMI in this register have previously been shown to have high positive predictive values (>85%). [21] [22] [23] [24] The majority of AS diagnoses in these registries have previously been shown to be based on echocardiographic measurements, and to mainly comprise moderate to severe stenosis. 22 Mortality was ascertained through linkage of subjects in the HDR and the Swedish Population Register to the Swedish Cause of Death Register (CDR), using the unique 10-digit personal identification number which all Swedish residents receive upon birth or immigration. 25 This personal identification number was replaced by a serial number for all data linkages in order to protect the anonymity of individuals. The CDR includes information on date and underlying causes of death for all Swedish citizens, both when occurring in Sweden and abroad. 26 
Diagnostic definitions
Diagnoses in the HDR and CDR were based on WHO's International Classification of Diseases (ICD). The 8 th version of ICD was used from 1969 until 1986, the 9 th version of ICD was used between 1987 and 1996, and the 10 th version from 1997 and onwards. Surgical and endovascular procedures in the HDR are coded based on a Swedish adaptation of the classification of surgical procedures from the Nordic Medico-Statistical Committee (NOMESCO), and used the Op6 classification from 1963 until 1989 and the KKÅ classification since then. 27 AS was defined as diagnosis codes 395.00 or 395.02 (ICD-8), 424B (ICD-9) or 135.0 (ICD-10). HF was defined as diagnosis codes 427.00 or 427.10 (ICD-8), 428 (ICD-9), I50.0, I50.1, I50.9 or I11.0 (ICD-10). AMI was defined as diagnosis codes 410.00 or 410.99 (ICD-8), 410 (ICD-9) or I21 (ICD-10). Cardiovascular mortality was defined as diagnosis codes 390-459 (ICD-9) or any I code (ICD-10) as cause of death in the CDR.
Aortic valve replacement for AS was defined as a diagnosis code of AS in combination with a procedure code of 3074, 3075, 3116, 3117 or 3078 (Op6), FMA or FMD (KKÅ). Surgical AVR was defined as procedure codes 3074, 3075, 3116, 3117 or 3078 (Op6), FMD00, FMD10, FMD20, FMD30, FMD33, FMD40 or FMD96 (KKÅ). TAVR was defined as FMD12 or FMD13 (KKÅ). Other surgical procedures for AS, including valve dilation and valvuloplasty, were also ascertained and defined as FMA00, FMA10, FMA20, FMA32 or FMA96 (KKÅ).
Statistical analysis
Patients with a first primary discharge diagnosis of AS, HF or AMI between 1989-2009 were divided into seven groups based on 3-year time periods: 1989-1991, 1992-1994, 1995-1997, 1998-2000, 2001-2003, 2004-2006, 2007-2009 . Patients diagnosed prior to January 1, 1989 were excluded from all analyses, as registers were incomplete before this time. In secondary analyses, 50.1, I50.9 or I11.0 (ICD-10). AMI was defined as diagnosis codes 410.00 or 4 41 10 10.9 .9 99 9 (I (I (ICD CD CD-8 -8 -8) ), 410 (ICD-9) or I21 (ICD-10). Cardiovascular mortality was defined as diagnosis codes 390-459 I ICD CD D-9 -9 -9) ) ) or or or a an n ny I I c c co od ode (ICD-10) as cause of death th th in n n the CDR. all patients diagnosed between 2001-2009 with AS either upon hospital discharge or at outpatient clinics were studied.
To test the hypothesis that incidence and prognosis of AS changed over time with greater magnitude than would be expected by random fluctuations in the population, incidence and mortality rates were calculated with 95% confidence intervals under the assumption of a Poisson distribution. For each time period, we calculated crude, sex-specific and age-adjusted incidence and mortality rates at 1 and 3 years, respectively. Age stratification was performed with weighting according to the European Standard Population. 28 Cox proportional hazards regression models were used to calculate age-and sex-adjusted hazard ratios (HR) for mortality at 1 and 3 years, for each time period compared to the first time period (1989-91). Cardiovascular mortality was explored as a separate endpoint (in addition to all-cause mortality).
The proportion of AS patients undergoing AVR for each time period was computed at 1 and 3 years as well as the entire follow-up period until December 31, 2010. Procedural mortality was evaluated across all time periods as 30-day mortality following AVR.
All statistical analyses were performed in SAS version 9.3 (SAS Institute Inc. Cary, NC, USA). A two-sided P value < 0.05 was considered statistical significant.
Results
Trends in incidence of aortic stenosis
The total number of AS cases increased from 4,694 in 1989-1991 to 5,963 in 2007-2009, as shown in Table 1 . Crude incidence rates for AS remained stable for both men (23. All st tat at atis is sti ti ica ca cal l an an anal a ys ys yses es es w w wer er ere e pe pe p rf rf rfor or orme me med d d in in in SA SA SAS S ve ve vers rs rsio io on n n 9. 9. 9. during the total follow-up period did so in the first 3 years following diagnosis ( Table 1) .
Trends in mortality for aortic stenosis
Mortality rates at 1 and 3 years declined for AS, HF and AMI ( Analyses of relative risk of mortality with AS across time periods yielded consistent results with improved prognosis as shown in Table 3 and illustrated in Figure 1 . Most of the improvement seems to have occurred in the 1990s, while only limited improvements were observed compared to 1998-2000 in later time periods.
Cardiovascular and postoperative mortality
The relative risk of cause-specific mortality from cardiovascular disease ( Supplementary table   during the total follow-up period did so in the first 3 years following diagnosis ( ( n T Ta Tabl bl b e e 1 1 1). ). ).
Trends in mortality for aortic stenosis
Mo Mo ort rt rtal al alit it ity y ra ra rate te tes at at t 1 1 1 and 3 years declined for AS, , HF HF HF and AMI (Ta Ta abl b e e 2 2 2 a a and n Supplementary a abl bl le e 2). Consi sist st ten n nt tr tr ren en nds ds ds w w wer er ere e ob ob obs s ser erve ve ed fo o or b both h h m men n n a and nd d w w wom om me en n.
Th The e e a ag age-e-ad ad adju ju j st st ted d d m mor or rta tali li lity ty ty r r rat ate e e at at at 1 1 1 y yea ea ear r a a als Postoperative mortality during 30 days after AVR also declined in the 1990s, but not further at later time periods ( Table 3) . Relative risk for both 1-year and 3-year mortality also declined in patients not undergoing surgery during follow-up (HR 0.61, 95% CI 0.55-0.67 and HR 0.62, 95% CI 0.57-0.67, respectively) as shown in Supplementary table 3 .
Sensitivity analyses
Patients diagnosed with AS before and after 75 years of age were studied separately as a sensitivity analysis (Supplementary table 4 and 5). More than 60% of AS patients diagnosed before 75 years were men, whereas more than 50% of AS patients diagnosed after 75 years were women. Incidence rate of AS and mortality after AS was higher in the population older than 75 years. However, declining incidence and mortality was consistently observed in both age groups. Table 7 ).
before 75 years were men, whereas more than 50% of AS patients diagnosed aft fte e er 7 7 75 5 ye ye year ar ars s s we we w re women. Incidence rate of AS and mortality after AS was higher in the population older than 75 ye year ar ars. s. . H H How ow wev ev ver, , de de decl c ining incidence and mortal lit it ity y w was consistent nt tly l l o obs bs bse er erved in both age groups. 
Discussion
In this nation-wide study of temporal trends in aortic stenosis we observed that, despite an aging population, the unadjusted incidence of AS remained stable whereas the age-adjusted incidence declined in Sweden over the past 20 years. Further, although the median age at diagnosis increased by 4 years, mortality in AS declined markedly, similar to the trends described here and in previous reports from other countries for HF and AMI. [9] [10] [11] [12] [13] These developments principally occurred during the 1990s, with limited improvement observed in the 21 st century.
Patient characteristics and incidence
Most cases of AS in western countries are considered to represent aging-degenerative disease and its development may be augmented by the presence of traditional cardiovascular risk factors.
The median age at diagnosis increased over the study period, as might be expected based on Sweden's demographics with an aging population and the strong correlation of AS with age in the general population. 1 More importantly, the crude incidence rates of AS did not change significantly during the study period but the age-adjusted incidence declined. Because age may be viewed as the cumulative time of exposure to risk factors our observations could, therefore, suggest that AS is a preventable disease process through tight risk factor control. Indeed, several cardiovascular risk factors have declined throughout the last couple of decades in the Western world (including Sweden), which would be in agreement with this view. [29] [30] Moreover, trends in incidence of AS followed those observed for AMI and HF, which would be consistent with n previous reports from other countries for HF and AMI. [9] [10] [11] [12] [13] These development nts s s pr pr p in n nc ci cipa pa pall ll lly y y occurred during the 1990s, with limited improvement observed in the 21 st century. are currently the only therapeutic options to reduce mortality and morbidity in AS. However, such interventions are associated with a non-negligible risk for complications and mortality. [35] [36] [37] No medical therapies have been shown to be efficacious, although some studies have suggested positive effects of ACE inhibitors. [33] [34] In the current study, we observed a clear improvement in prognosis after AS diagnosis, despite the increasing age at diagnosis and the fact that the only novel effective therapy for AS to appear during the study period was TAVR, which only began to emerge in the last time period studied. The proportion of patients undergoing AVR remained relatively stable during the study which may, although not directly aimed at prevention of AS, have translated int to o be be ene ne efi fi fits ts ts f f for or o A AS as well as for atherosclerotic vascular diseases. period, but increased slightly in the last time period, and increased in patients >75 years at diagnosis. Almost all patients who underwent surgery did so within three years of diagnosis.
Pr rog og ogno no no i si sis s s an an and va va val lv lve replacement
Importantly, we noticed a clear and significant reduction in 30-day mortality after AVR. This finding is in line with previous studies and might have contributed to improved survival for patients diagnosed with aortic stenosis. [38] [39] This hypothesis is strengthened by the fact that both 1-and 3-year mortality has seen a similar improvement, which supports the notion that the aortic stenosis, but larger studies are warranted for firm conclusions. 41 Lipid-lowering medications is unlikely to confer direct beneficial effects on AS, as three randomized trials did not observe effect on progression of established AS. [42] [43] [44] 
Conclusion
In summary, the incidence of AS and mortality in AS patients declined in Sweden during the past 20 years, similar to the decline seen in HF and AMI. This development principally occurred during the 1990s, with limited further improvement in the 21 st century. These trends likely reflect improved risk factor control and therapy for common comorbidities such as AMI and HF, combined with increased utilization of AVR in the elderly and a reduction in perioperative mortality after AVR. .3) ) ) 12 12 1 .6 .6 (1 (1 (12 2. 2.1-1-1 13 3 13 1 .1 .1) ) ) 10 10.7 (1 (1 (10 0. 0.3-3-3 11 11 11.1 .1 1) . 9 9 9 (9 (9 (9.5 .5 5 1 -1 10. 0 0 3) 3) 3 10 10 1 .3 .3 (9 (9 (9 9 .9 .9 1 -10. 0.7) 7) 7)
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1-year mortality 1989-1991 1992-1994 1995-1997 1998-2000 Hazard ratios for mortality are from Cox proportional hazards regression analyses adjusted for sex and age. AS, aortic stenosis. HR, hazard ratio.
